CDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processing
Judith Pirngruber1, Andrei Shchebet, Lisa Schreiber
1Department of Molecular Oncology, Göttingen Center for Molecular Biosciences, University of Göttingen, Göttingen, Germany.
EMBO Reports
|July 4, 2009
Summary
Cyclin-dependent kinase 9 (CDK9) is crucial for maintaining histone H2B monoubiquitination (H2Bub1) and proper histone mRNA processing. This research reveals CDK9
Area of Science:
- Molecular Biology
- Epigenetics
- Gene Regulation
Background:
- Post-translational histone modifications regulate nuclear processes, but their regulatory mechanisms are not fully understood.
- Cyclin-dependent kinase 9 (CDK9) is known to regulate gene expression through phosphorylation of transcriptional proteins.
- Histone H2B monoubiquitination (H2Bub1) is a key epigenetic modification involved in gene regulation.
Purpose of the Study:
- To investigate the role of CDK9 in regulating histone modifications, specifically H2Bub1.
- To determine the impact of CDK9 activity on histone mRNA 3'-end processing.
- To elucidate the interplay between CDK9-mediated phosphorylation and chromatin modifications in controlling gene expression.
Main Methods:
- Utilized CDK9 knockdown experiments to assess its effects on H2Bub1 levels.
- Analyzed mRNA 3'-end processing efficiency and polyadenylation signals in CDK9-depleted cells.
- Investigated the functional link between CDK9, H2Bub1, and co-transcriptional processing of histone mRNAs.
Main Results:
- CDK9 activity was found to be essential for maintaining global and gene-associated H2Bub1 levels.
- CDK9 and H2Bub1 are critical for the accurate 3'-end processing of replication-dependent histone mRNAs.
- CDK9 knockdown led to inefficient mRNA 3'-end cleavage and increased read-through transcription.
Conclusions:
- CDK9 plays a vital role in maintaining H2Bub1, a key histone modification.
- CDK9 and H2Bub1 are essential for correct histone mRNA 3'-end processing.
- CDK9 integrates transcriptional phosphorylation with chromatin modifications to control co-transcriptional histone mRNA processing.
Related Concept Videos
02:38S-Cdk Initiates DNA Replication
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
02:38S-Cdk Initiates DNA Replication
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.